Awakn Life Sciences Corp. (AWKNF)

0.1305 0.0000 (0.00%) As of 03:43PM EDT. Market open.

Awakn Life Sciences Corp.

301-217 Queen Street West
Toronto, ON M5V 0R2
Canada

https://awaknlifesciences.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 44

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. George Scorsis	Co-founder & Chairman of the Board	N/A	N/A	1978
Mr. Anthony Tennyson	Co-founder, President, CEO & Director	175.27k	N/A	N/A
Mr. Jonathan James Held C.A., CPA, CA	Interim CFO, Chief Business Officer & Secretary	109.55k	N/A	1986
Prof. David John Nutt DM, FMedSci, FRCP, FRCPsych, FSB, Ph.D.	Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer	N/A	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

Corporate Governance

Awakn Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.